Seyhan Çankaya
Konya, 42250, Turkey (Türkiye)
Location status: Recruiting
NCT Number: NCT07660393
The Effect of Virtual Reality Glass Use on Fetal Health Anxiety, Prenatal Distress, and Maternal-Fetal Attachment in Women with Premature Rupture of Membranes: A Randomized Controlled Trial
Interested in participating?
Request Info18 year–50 year
Female
Interventional
Not applicable
Konya, 42250, Turkey (Türkiye)
Location status: Recruiting
This study is a randomized controlled trial. The study population will consist of nulliparous pregnant women hospitalized with a diagnosis of preterm premature rupture of membranes (PPROM) in the Perinatology Clinic of Konya City Hospital between June 2025 and January 2027. A total of 176 pregnant women who will be giving birth for the first time will be included in the study (intervention group: n = 88; control group: n = 88). In the intervention group, pregnant women with PPROM will watch a nature-themed video accompanied by natural sounds selected by the researchers through a virtual reality headset (VRH) twice daily for three consecutive days, with each session lasting at least five minutes. The control group will receive the standard antenatal care provided by the hospital. Data will be collected using a Personal Information Form, the Fetal Health Anxiety Scale, the Prenatal Distress Questionnaire, and the Prenatal Attachment Inventory.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The control group will receive standard prenatal care and treatment provided by the hospital.
After the study is completed, control group participants will be shown nature-themed videos via Virtual Reality Glasses (VRG) if they wish.
Pregnant women with premise rupture of membranes (PRM) in the intervention group will be shown a nature-themed video prepared by the researchers with nature sounds via Virtual Reality Glasses (VRG) twice a day for at least five minutes each time for three days.
Time frame: 6 months
Sociodemographic information of pregnant women will be collected, compared, and reported through questionnaires.
Time frame: 6 months
The Fetal Health Concern Scale will be administered to pregnant women.
The Fetal Health Concern Scale ranges from 0 to 42 points (minimum-maximum), with higher scores indicating greater fetal health concern.
Time frame: 6 months
The Prenatal Distress Scale will be administered to all pregnant women.
The Prenatal Distress Scale ranges from 0 to 34 points (minimum-maximum), with higher scores indicating greater prenatal distress.
Time frame: 6 months
The Prenatal Attachment Inventory will be administered to all pregnant women.
The Prenatal Attachment Inventory score ranges from 21 to 84 points (minimum-maximum), with higher scores indicating greater prenatal distress.
Contact information is provided by the study sponsor or research team.
Selcuk University
Other
The Effect of Virtual Reality Glass Use on Fetal Health Anxiety, Prenatal Distress, and Maternal-Fetal Attachment in Women With Premature Rupture of Membranes: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05954754
Coping With Prenatal Stress, Fetal Health Anxiety
Elâzığ, Province, Turkey (Türkiye)
View Trial DetailsNCT07263750
Fear of Childbirth, Prenatal Attachment
Merkez, Sivas, Turkey (Türkiye)
View Trial DetailsNCT07154459
Behavior, Breast Feeding
Tokat Province, Center, Turkey (Türkiye)
View Trial DetailsNCT07122115
PRENATAL DISTRESS
Kayseri, Kocasi̇nan, Turkey (Türkiye)
View Trial Details